Johnson & Johnson said Tuesday it will report the results of its coronavirus vaccine trial by next week, potentially placing the immunization campaign on a speedier trajectory as economies reel and nations tighten their borders against fast-moving variants.

U.S. officials are desperate to gain approval of J&J’s one-dose vaccine as …
Source: The Washington Times